 HOUSTON and VANCOUVER, BC, Oct. 26, 2020 PRNewswire - ESSA Pharma Inc. ESSA or the Company TSX-V: EPI NASDAQ: EPIX, a clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced today its intention to voluntarily... 